Metabolic Syndrome 2011
DOI: 10.1002/9780470910016.ch4
|View full text |Cite
|
Sign up to set email alerts
|

Adipokine Production by Adipose Tissue: A Novel Target for Treating Metabolic Syndrome and its Sequelae

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2011
2011
2017
2017

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 471 publications
0
3
0
Order By: Relevance
“…In many of the studies cited here, changes in adipokine levels were observed in individuals with gene polymorphisms, and thus, the change in adipokine levels precedes the occurrence of pathological conditions. Varied downstream effects on parameters of health are to be expected, since the adipokines examined here play diverse roles in many organ systems, as recently reviewed by DeClercq et al [ 129 ]. The genetic variants included in this review by no means constitute an exhaustive list, and further investigation of adipokine SNPs and their impact on human health is warranted.…”
Section: Discussionmentioning
confidence: 98%
“…In many of the studies cited here, changes in adipokine levels were observed in individuals with gene polymorphisms, and thus, the change in adipokine levels precedes the occurrence of pathological conditions. Varied downstream effects on parameters of health are to be expected, since the adipokines examined here play diverse roles in many organ systems, as recently reviewed by DeClercq et al [ 129 ]. The genetic variants included in this review by no means constitute an exhaustive list, and further investigation of adipokine SNPs and their impact on human health is warranted.…”
Section: Discussionmentioning
confidence: 98%
“…Furthermore, adiponectin administration to obese or diabetic mice can reduce body weight and blood glucose levels while enhancing insulin sensitivity [18][19][20]. Based on these data, adiponectin was conceived to be a novel therapy target for obese and insulin resistance [21]. Elevation of adiponectin level by EGCG was documented in non-obese spontaneous diabetic rats and spontaneous hypertension rats [22,23].…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, adiponectin administration to obese or diabetic mice can reduce body weight and blood glucose levels while enhancing insulin sensitivity [14,15]. Based on these data, adiponectin was conceived to be a novel therapy target for obesity and insulin resistance [16].…”
Section: H O S T E D Bymentioning
confidence: 99%